Capital Research Global Investors Astrazeneca PLC Transaction History
Capital Research Global Investors
- $428 Billion
- Q1 2024
A detailed history of Capital Research Global Investors transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital Research Global Investors holds 1,390,657 shares of AZN stock, worth $108 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,390,657
Previous 1,736,665
19.92%
Holding current value
$108 Million
Previous $117 Million
19.45%
% of portfolio
0.02%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,246Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.78 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.83 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.35 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.69 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.35 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...